TITLE

The promise of stem cells

AUTHOR(S)
Gavaghan, Helen
PUB. DATE
August 2001
SOURCE
Bulletin of the World Health Organization;2001, Vol. 79 Issue 8, p800
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on potential of stem cell research to revolutionize the practice of medicine. Opposition to embryonic stem cell research on ethical grounds; Need for two types of stem cell work; Therapeutic potential of multipotent stem cells. INSET: Stem cells--some basic notions.
ACCESSION #
5475480

 

Related Articles

  • Old cells, new tricks. Martindale, Diane // New Scientist;08/19/2000, Vol. 167 Issue 2252, p16 

    Reports on the idea to bypass embryonic stem cells in stem cell research. Use of mature human stem cells as a substitute for embryonic stem cells; Versatility of stem cells; Ability of stem cells to create many kinds of tissue; Idea that brain stem cells could be as versatile as human embryo...

  • Amniotic Stem Cells: Potential in Regenerative Medicine. Bani-Yaghoub, Mahmud; Wilson, Patricia; Hengstschl√§ger, Markus; Nikaido, Toshio; Duanqing Pei // Stem Cells International;2012, p1 

    An introduction is presented in which the editor discusses various papers within the issue on topics including amniotic stem cells and their importance in regenerative therapy to repair damage tissue or organ.

  • The Complexities of Engineering Human Stem Cell-Derived Therapeutics. Hay, David C.; Ross, James A.; Gallagher, Ronnie; Bagnaninchi, Pierre // Journal of Biomedicine & Biotechnology;2010, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics related to human stem-cell derived therapeutics including one on the role of stem cells in the process of regeneration, carcinogenesis, and development by Kung et al., one on the expansion of...

  • Corrections.  // Nature Medicine;Jul2012, Vol. 18 Issue 7, p995 

    Corrections to two articles including "The vetting process" that was published in the June 2012 issue and ""Korea okays stem cell therapies despite limited peer-review data" that was published in the March 2012 issue are presented.

  • Medical Provision in the Twenty-First Century. Busia, Kofi // Journal of Alternative & Complementary Medicine;Apr2002, Vol. 8 Issue 2, p193 

    Discusses the impact of scientific breakthroughs in nuclear transfer and genetics on alternative medical practices in Great Britain. Reasons why alternative medicine practitioners should have a knowledge of medical breakthroughs; Focus of the debate surrounding stem cell therapy; Overview of...

  • Stem cell therapy in orthopaedics. Correa, Diego; Goldberg, Victor M. // AAOS Now;Jul2011, Vol. 5 Issue 7, p41 

    The article discusses the use of stem cell therapy in orthopaedics in the U.S. It mentions that the emerging field of regenerative medicine aims to overcome the tissue scarring process by providing the required elements such as cells and molecules to promote real tissue regeneration. It states...

  • GROWING A NEW YOU. BARTH, AMY // Discover;Mar2012, Vol. 33 Issue 2, p11 

    The article discusses research in regenerative medicine including the growth of bladders from baboon bone marrow stem cells, a synthetic windpipe grown using a patient's stem cells, and the regeneration of tissue using proteins from a pig's bladder.

  • Stem Cell Therapy: Future of Pain Medicine. YiLi Zhou; Bohdan Warycha; Hoang Vu // British Journal of Medical Practitioners;Sep2014, Vol. 7 Issue 3, p29 

    An introduction is presented in which the editor discusses various reports within the issue on topics including pain medicine, stem cell therapy and research, and the treatment for chronic back and knee pain.

  • Autologous Mesenchymal Stem Cell Therapy Delays the Progression of Neurological Deficits in Patients With Multiple System Atrophy. Lee, P. H.; Kim, J. W.; Bang, O. Y.; Ahn, Y. H.; Joo, I. S.; Huh, K. // Clinical Pharmacology & Therapeutics;May2008, Vol. 83 Issue 5, p723 

    We evaluated the feasibility and safety of therapy with mesenchymal stem cells (MSCs) through consecutively intra-arterial and three repeated intravenous injections and compared the long-term prognosis between MSC-treated (n=11) and control multiple system atrophy (MSA) patients (n=18). The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics